Skip to main content
Erschienen in: Neurological Sciences 8/2018

01.08.2018 | Original Article

The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients

verfasst von: Zehra Akdag Uzun, Semiha Kurt, Hatice Karaer Unaldi

Erschienen in: Neurological Sciences | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

In this study, we aimed to investigate restless legs syndrome, depression, frequency of fibromyalgia and possible causes of its frequencies, and the relationships among these synergies and migraine’s prodrome, aura, pain, and postdrome symptoms in patients with migraine.

Subjects and methods

The study group included 200 patients previously or recently diagnosed with definite migraine and according to International Headache Society criteria and 200 healthy volunteers. All subjects underwent a medical interview to confirm restless legs syndrome and fibromyalgia, and they were asked to complete Beck Depression and Anxiety Inventory and “severity of restless legs syndrome inventory.”

Results

The frequencies of depressive symptoms and fibromyalgia in the patients with migraine were higher than those of the control group. The mean age of the migraine patients with restless legs syndrome was also higher, and this group had migraine headache for a longer time. There was a statistically significant difference with regard to only generalized anxiety and traveler’s distress, which were features of the migraine, between migraine patients with and without restless legs syndrome. Restless legs syndrome was more common in migraine patients with and without aura and in those with nonspecific white matter lesions in the cranial MRI.

Conclusions

In our study, the greater frequency of restless legs syndrome, depressive symptoms, and fibromyalgia in the patients with migraine supports the role of dopamine, which is common to all three disorders. Interviews focused on these problems among migraine patients may help to decide on the best available treatment modality.
Literatur
1.
Zurück zum Zitat Silberstein SD, Lipton RB, Goadsby P (1998) Pathophysiology and epidemiology of headache. Headache in clinical practice. Isis Medical Media Ltd, Oxford, pp 11–40 Silberstein SD, Lipton RB, Goadsby P (1998) Pathophysiology and epidemiology of headache. Headache in clinical practice. Isis Medical Media Ltd, Oxford, pp 11–40
2.
3.
Zurück zum Zitat D’Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine in cluster headache. Headache 46:585–591CrossRefPubMed D’Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine in cluster headache. Headache 46:585–591CrossRefPubMed
4.
Zurück zum Zitat Fanciullacci M, Alessandri M, Del Rosso A (2000) Dopamine involvement in the migraine attack. Funct Neurol 15(Suppl. 3):171–181PubMed Fanciullacci M, Alessandri M, Del Rosso A (2000) Dopamine involvement in the migraine attack. Funct Neurol 15(Suppl. 3):171–181PubMed
5.
Zurück zum Zitat Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009–1013CrossRefPubMed Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009–1013CrossRefPubMed
6.
Zurück zum Zitat Chokroverty S (2008) Sleep and its disorders. In: Bradley GW, Daroff BR (eds) Neurology in clinical practice, 5th edn. Butterworth- Heinemann Elsevier, Philadelphia, pp 1947–2009CrossRef Chokroverty S (2008) Sleep and its disorders. In: Bradley GW, Daroff BR (eds) Neurology in clinical practice, 5th edn. Butterworth- Heinemann Elsevier, Philadelphia, pp 1947–2009CrossRef
7.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Michael Franklin C, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, John Reynolds W, Romano TJ, Jon Russell I, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Michael Franklin C, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, John Reynolds W, Romano TJ, Jon Russell I, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed
8.
Zurück zum Zitat Stehlik R, Arvidsson L, Ulfberg J (2009) Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 61:107–111CrossRefPubMed Stehlik R, Arvidsson L, Ulfberg J (2009) Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 61:107–111CrossRefPubMed
9.
Zurück zum Zitat Sabayan B, Bagheri M, Haghighi AB (2007) Possible joint origin of restless leg syndrome (RLS) and migraine. Med Hypotheses 69:64–66CrossRefPubMed Sabayan B, Bagheri M, Haghighi AB (2007) Possible joint origin of restless leg syndrome (RLS) and migraine. Med Hypotheses 69:64–66CrossRefPubMed
10.
Zurück zum Zitat Rhode AM, Hösing VG, Happe S, Biehl K, Young P, Evers S (2007) Comorbidity of migraine and restless legs syndrome—a case control study. Cephalalgia 27:1255–1260CrossRefPubMed Rhode AM, Hösing VG, Happe S, Biehl K, Young P, Evers S (2007) Comorbidity of migraine and restless legs syndrome—a case control study. Cephalalgia 27:1255–1260CrossRefPubMed
12.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders: 2nd edn. Cephalalgia 24(Suppl. 1):9–160 Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders: 2nd edn. Cephalalgia 24(Suppl. 1):9–160
13.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
14.
Zurück zum Zitat The international Restless Legs Syndrome Study Group (2003) Validation of the international Restless Legs Syndrome Study Group Rating Scale for restless legs syndrome. Sleep Med 4:121–132CrossRef The international Restless Legs Syndrome Study Group (2003) Validation of the international Restless Legs Syndrome Study Group Rating Scale for restless legs syndrome. Sleep Med 4:121–132CrossRef
15.
Zurück zum Zitat Hening WA, Allen RP (2003) Restless legs syndrome (RLS) the continuing development of diagnostic standards and severity measures. Editorial. Sleep Med 4:95–97CrossRefPubMed Hening WA, Allen RP (2003) Restless legs syndrome (RLS) the continuing development of diagnostic standards and severity measures. Editorial. Sleep Med 4:95–97CrossRefPubMed
16.
Zurück zum Zitat Rains JC, Poceta JS (2006) Headache and sleep disorders: review and clinical implications for headache management. Headache 46(9):1344–1363CrossRefPubMed Rains JC, Poceta JS (2006) Headache and sleep disorders: review and clinical implications for headache management. Headache 46(9):1344–1363CrossRefPubMed
18.
Zurück zum Zitat Young WB, Piovesan WJ, Biglan KM (2003) Restless legs syndrome and drug-induced akathisia in headache patients. CNS Spectr 8:450–456CrossRefPubMed Young WB, Piovesan WJ, Biglan KM (2003) Restless legs syndrome and drug-induced akathisia in headache patients. CNS Spectr 8:450–456CrossRefPubMed
19.
Zurück zum Zitat Valente M, Janes F, Russo V, Fontana A, Travanut A, Sommaro M, Canal G, Gentile C, Luigi Gigli G (2017) Prevalence of restless legs syndrome in migraine patients: a case-control study. Analysis of risk factors for restless legs syndrome in migraine patients. Headache 57(7):1088–1095. https://doi.org/10.1111/head.13124 CrossRefPubMed Valente M, Janes F, Russo V, Fontana A, Travanut A, Sommaro M, Canal G, Gentile C, Luigi Gigli G (2017) Prevalence of restless legs syndrome in migraine patients: a case-control study. Analysis of risk factors for restless legs syndrome in migraine patients. Headache 57(7):1088–1095. https://​doi.​org/​10.​1111/​head.​13124 CrossRefPubMed
21.
Zurück zum Zitat Le H, Tfelt-Hansen P, Russell MB et al (2011) Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31(1):43–64CrossRefPubMed Le H, Tfelt-Hansen P, Russell MB et al (2011) Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31(1):43–64CrossRefPubMed
22.
Zurück zum Zitat Frediani F, Villani V (2007) Migraine and depression. Neurol Sci 28(Suppl 2):161–165CrossRef Frediani F, Villani V (2007) Migraine and depression. Neurol Sci 28(Suppl 2):161–165CrossRef
24.
Zurück zum Zitat Reus VI (2001) Psychiatric disorders. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 2542–2557 Reus VI (2001) Psychiatric disorders. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 2542–2557
25.
Zurück zum Zitat Gilliland BC (2001) Relapsing polychondritis and other arthritides. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 2005–2016 Gilliland BC (2001) Relapsing polychondritis and other arthritides. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 2005–2016
26.
Zurück zum Zitat Wood PB, Glabus MF, Simpson R, Patterson JC (2009) Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 10(6):609–618CrossRefPubMed Wood PB, Glabus MF, Simpson R, Patterson JC (2009) Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 10(6):609–618CrossRefPubMed
Metadaten
Titel
The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients
verfasst von
Zehra Akdag Uzun
Semiha Kurt
Hatice Karaer Unaldi
Publikationsdatum
01.08.2018
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 8/2018
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3438-7

Weitere Artikel der Ausgabe 8/2018

Neurological Sciences 8/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.